| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193655 | Annals of Allergy, Asthma & Immunology | 2006 | 6 Pages |
Abstract
Patients with difficult-to-treat asthma may benefit from receiving omalizumab even if they fall outside current dosing guidelines because of high body weight.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Kwong Kenny Y.C., Jones Craig A.,